The startup Haemanthus, reportedly co-founded by Billy Evans, is stirring controversy due to its resemblance to the disgraced Theranos, co-founded by Elizabeth Holmes. While Holmes is barred from working in healthcare for ten years following her conviction, her partner has launched a blood-testing company that has reportedly raised around $20 million. Named after a blood lily, Haemanthus aims to raise $50 million to develop testing devices for multiple bodily fluids in animals. Its launch raises ethical questions about influence and accountability in the industry following Theranos's collapse.
Haemanthus, a new blood-testing startup co-founded by Billy Evans, evokes memories of Theranos, raising concerns about its legitimacy and the ethics of its inception.
Despite being under a court order not to work in the healthcare industry, Holmes's partner is launching a startup that might reflect her controversial legacy.
Haemanthus has reportedly secured $20 million in funding with ambitions to raise an additional $50 million for developing their testing devices.
The emergence of Haemanthus brings forth discussions of ethics and innovation in healthcare, especially relating to the legacy of Elizabeth Holmes and Theranos.
Collection
[
|
...
]